# Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects

> **NCT04108676** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Fluzoparib
- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT04108676
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-07
- **Primary completion:** 2019-09-18
- **Final completion:** 2019-11-18
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2022-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04108676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04108676, "Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04108676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*